Log-in
Sign-up
Webcast
Clinical Trials
Library
Webcast
Clinical Trials
Library
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
Terminated
NCT04606563
Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?
341
Enrollment(s)
13
Study location(s)
Interventional (Phase III)
Covid19
SARS-CoV Infection
Active, not recruiting
NCT04594915
Evaluation of Treatment Safety in Patients With Atrial Fibrillation on Edoxaban Therapy in Real-Life in Turkey
1,053
Enrollment(s)
45
Study location(s)
Observational
Atrial Fibrillation
Not yet recruiting
NCT05723510
PK and PD Interaction Between Tegoprazan and NOACs After Multiple Oral Dosing in Healthy Volunteers
76
Enrollment(s)
0
Study location(s)
Interventional (Phase I)
Healthy
Completed
NCT01944800
Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome
4,018
Enrollment(s)
19
Study location(s)
Interventional (Phase IV)
Acute Coronary Syndrome (ACS)
Completed
NCT03882177
StAT-TB (Statin Adjunctive Therapy for TB): A Phase 2b Dose-finding Study of Pravastatin in Adults With Tuberculosis
35
Enrollment(s)
1
Study location(s)
Interventional (Phase II)
Tuberculosis
Pulmonary Tuberculosis
Completed
NCT04796831
A Study to Determine the Absolute Oral Bioavailability of Quizartinib Using a Radiolabeled Microtracer in Healthy Subjects
8
Enrollment(s)
1
Study location(s)
Interventional (Phase I)
Healthy Subjects
Recruiting
NCT04297150
Predictive Factors for Response to New Oral Anticoagulants in the Treatment of Non-valvular Atrial Fibrillation..
700
Enrollment(s)
6
Study location(s)
Observational
Atrial Fibrillation
Completed
NCT03757481
Long-term Outcome After Heparin and Edoxaban Versus Heparin Plus Vit K Antagonists for Acute DVT and PE
156
Enrollment(s)
11
Study location(s)
Interventional (Not Applicable)
Post Thrombotic Syndrome
Deep Vein Thrombosis
Chronic Thromboembolic Pulmonary Hypertension
36
37
38
39
40